@Estherluciam @RawdyReales No es lo mismo mi querida saltamontes. https://t.co/5vDpMXzljW
@oneinch_ceo @hirox246 CBDの有効性を示す最高峰に権威の高い論文(ソース)も、かなり前に多数報告されており、大麻成分は非常にホットな研究対象です! 1)https://t.co/emJ8h5LvgW 2)https://t.co/kTZN2p6iTG 3)https://t.co/VLUYRrdBEh 4)https://t.co/f86nv8cHGg これらエビデンスはほんの一部です。
Ensayo fase III de la serie GWPCARE, en este caso el 4. Se trata de un ensayo multicentricéntrico, aleatorizado en doble ciego. Como en los otros de la serie y afines,la tolerabilidad,seguridad y eficacia del #CBD como coadyuvante es muy remarcable. htt
難治性のけいれん(ドラベ症候群、レノックス・ガストー症候群)に対する大麻由来製剤の効果については、こちらのスレッドを。 https://t.co/vzdgHHj7hJ
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
@drjorgemarin Cannabis medicinal es muy diferente de hablar de cannabidiol, con ensayo clínico publicado, dosis establecida y eventos adversos. https://t.co/08W4mO8rh8
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. https://t.co/YLvI7udgaf #CBD #hemp #cannabidiol # Lennox-Gastautsyndrome
レノックス-ガストー症候群(GWPCARE4)に関連する発作患者のカンナビジオール:無作為化二重盲検プラセボ対照第3相試験。 https://t.co/R5qXFsyLOl https://t.co/YLvI7udgaf #ヘンプ論文 #レノックス-ガストー症候群
@GuilleFav @19_buenas Igual, si un médico te dice que CBD no funciona, no esta al día!! Su uso y recomendación esta claro: epilepsia refractaria. https://t.co/1WqVHIwKGt y https://t.co/6DAJsMM5tg
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
@medicoinquieto El problema esta en las expectativas que generan. Con peor evidencia prometen mejores resultados. https://t.co/YvmDPYtMq2
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
@ngenesoni1
@miranda_marite
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
RT @PabloRichly: Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales de…
Dado que los estudios sobre epilepsia refractaria de buena calidad muestran datos mucho más modestos, los profesionales del Garrahan deberían ser más cuidadoso con lo que afirma en los medios. 1) https://t.co/Hckh2HyLUm 2) https://t.co/oP85yjhru5 3) https
Do Lancet: uso de CBD em pacientes portadores da síndrome de Lennox-Gastaut (encefalopatia epilética severa, com frenquente resistência à medicação); Mostrando uma redução na frequência de eventos epiléticos mensais de até 43%. https://t.co/zoUzjdJniF
From the Lancet: CBD use in patients with Lennox-Gastaut syndrome (severe epiletic syndrome with frequent drug resistance); showing a reduction of monthly drop seizure frequency up to 43%, with mild to moderate adverse effects https://t.co/zoUzjdJniF
@Faaz71 @vocnederland Ok, my bad. Maar ze zijn al aardig op weg met studies over CBD en schizofrenie (zonder THC omdat dát het juist opwekt) en bij epilepsie bij kinderen https://t.co/uTIf78zzMB Overigens helpt 'gewoon blowen' mij wel/ook met mijn eeuwige
RT @BryonAdinoff: A randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol in patients with seizures associated with Len…
RT @BryonAdinoff: A randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol in patients with seizures associated with Len…
RT @BryonAdinoff: A randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol in patients with seizures associated with Len…
RT @BryonAdinoff: A randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol in patients with seizures associated with Len…
RT @BryonAdinoff: A randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol in patients with seizures associated with Len…
#cannabidiol #CBD for treatment resistant epilepsy (specifically, Lennox Gestaut syndrome). Placebo RCT, n=171. “median percentage reduction- monthly drop seizure frequency from baseline was 43·9% (IQR −69·6 to −1·9) in cannibidiol group and 21·8% (IQR −45
RT @BryonAdinoff: A randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol in patients with seizures associated with Len…
RT @BryonAdinoff: A randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol in patients with seizures associated with Len…
RT @editor_AJDAA: A randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol in patients with seizures associated with Len…
RT @BryonAdinoff: A randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol in patients with seizures associated with Len…
A randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome https://t.co/B7NETjgkyK #medicalmarijuana #dfcrorg
A randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome https://t.co/2VxAwRcNBj #medicalmarijuana
@adrianasalud Eso es diferente a marihuana medicinal. https://t.co/y3wLWZWAvS https://t.co/624l61MsIv
@MedCrisis Atleast three phase 3 trials now confirming efficacy. Safety profile much milder than other conventional alternatives. https://t.co/YQ2BVu8bhy
RT @AmirEnglund: @profhrs Important to remember that this just the long-term safety in a small sample. For efficacy you should check out th…
@profhrs Important to remember that this just the long-term safety in a small sample. For efficacy you should check out the Ph III studies: https://t.co/kXikJa924K https://t.co/kw26F5QQXd https://t.co/dNuJ3TFvEO
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial https://t.co/IgyARAyqPq
RT @griz1: #Cannabidiol #CBD [#Epidiolex] for treatment of #LennoxGastautSyndrome #LGS. Effective with & without #clobazam. #DrSHussain @UC…
RT @griz1: #Cannabidiol #CBD [#Epidiolex] for treatment of #LennoxGastautSyndrome #LGS. Effective with & without #clobazam. #DrSHussain @UC…
#Cannabidiol #CBD [#Epidiolex] for treatment of #LennoxGastautSyndrome #LGS. Effective with & without #clobazam. #DrSHussain @UCLAMCH @UCLAHealth @dgsomucla @IlaeWeb @PedCritCareMed @AmEpilepsySoc @CNS_Connect @PedNeurBriefs https://t.co/jpEgMfJNr7 ht
RT @neurochecklists: Cannabidiol in Lennox-Gastaut syndrome https://t.co/5N4rNQIc8K
RT @neurochecklists: Cannabidiol in Lennox-Gastaut syndrome https://t.co/5N4rNQIc8K
RT @neurochecklists: Cannabidiol in Lennox-Gastaut syndrome https://t.co/5N4rNQIc8K
RT @neurochecklists: Cannabidiol in Lennox-Gastaut syndrome https://t.co/5N4rNQIc8K
Cannabidiol in Lennox-Gastaut syndrome https://t.co/5N4rNQIc8K
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
Interesting and short article on cannabis derivatives for medical use. https://t.co/J90M8tGrvh
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…